Survivors of acute lymphoblastic leukemia and body mass changes
- PMID: 20001758
- DOI: 10.1517/14740330903410213
Survivors of acute lymphoblastic leukemia and body mass changes
Abstract
Importance of the field: Obesity is a rapidly growing challenge that has now reached epidemic proportions. Along with malnutrition, it causes increasing morbidity and mortality in the general population. Survivors of pediatric leukemia are at increased risk of developing adverse body mass changes. Despite many studies, mechanisms of regulation of fat tissue metabolism are still poorly understood.
Areas covered in this review: The present article reviews the data from studies of leukemia survivors in the context of basic science studies and reports of nutritional situation in Europe published between 1994 and 2009. As regulation of appetite and energy balance is very complex, environmental, biochemical and genetic factors are presented.
What the reader will gain: Fat mass and obesity associated gene (FTO) has recently been found to contribute to the risk of obesity. The possible role of this gene as well as late consequences of body mass changes are discussed.
Take home message: Both underweight and overweight leukemia survivors need to be monitored for ongoing health consequences of abnormal BMI. Parameters of metabolic syndrome should be included as routine assessments in outpatient clinics taking care of childhood leukemia survivors.
Similar articles
-
Long-term effects on growth, development, and metabolism of ALL treatment in childhood.Expert Rev Endocrinol Metab. 2019 Jan;14(1):49-61. doi: 10.1080/17446651.2019.1561271. Epub 2018 Dec 31. Expert Rev Endocrinol Metab. 2019. PMID: 30596296 Review.
-
Trajectories of Obesity and Overweight Rates Among Survivors of Childhood Acute Lymphoblastic Leukemia.Oncol Nurs Forum. 2015 Jul;42(4):E287-93. doi: 10.1188/15.ONF.E287-E293. Oncol Nurs Forum. 2015. PMID: 26148325
-
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology Group.Pediatr Blood Cancer. 2015 Jun;62(6):1035-41. doi: 10.1002/pbc.25411. Epub 2015 Feb 7. Pediatr Blood Cancer. 2015. PMID: 25663378 Free PMC article.
-
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.J Genet. 2011 Aug;90(2):365-8. doi: 10.1007/s12041-011-0089-3. J Genet. 2011. PMID: 21869491 No abstract available.
-
Metabolic syndrome in the survivors of childhood acute lymphoblastic leukaemia.Obes Res Clin Pract. 2015 Mar-Apr;9(2):114-24. doi: 10.1016/j.orcp.2014.06.004. Epub 2014 Jul 15. Obes Res Clin Pract. 2015. PMID: 25081809 Review.
Cited by
-
Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Expert Rev Hematol. 2011 Apr;4(2):185-97. doi: 10.1586/ehm.11.8. Expert Rev Hematol. 2011. PMID: 21495928 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials